JAK/STAT Signalling in Huntington's Disease Immune Cells

PLoS Currents

Volumn , Issue DEC, 2013, Pages

  Träger, Ulrike ^a   Magnusson, Anna ^b   Lahiri Swales, Nayana ^c   Wild, Edward ^a,d   North, Janet ^c   Lowdell, Mark ^c   Björkqvist, Maria ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE; STAT PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUNTINGTON CHOREA; IMMUNOCOMPETENT CELL; MALE; MIDDLE AGED; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84940273713     PISSN: None     EISSN: 21573999     Source Type: Journal    
DOI: 10.1371/currents.hd.5791c897b5c3bebeed93b1d1da0c0648     Document Type: Article

References (23)

1. Bates G, Harper PS, Jones L, editors (2002) Huntington's Disease. Oxford: Oxford University Press.
2. Li SH, Schilling G, Young WS, Li XJ, Margolis RL,et al. (1993) Huntington's disease gene (IT15) is widely expressed in human and rat tissues. Neuron 11: 985-993.
3. van der Burg JM, Björkqvist M, Brundin P (2009) Beyond the brain: widespread pathology in Huntington's disease. Lancet Neurol 8: 765-774.
4. Björkqvist M, Wild EJ, Thiele J, Silvestroni A, Andre R,et al. (2008) A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease. J Exp Med 205: 1869-1877.
5. Weiss A, Träger U, Wild EJ, Grueninger S, Farmer R,et al. (2012) Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression. J Clin Invest 122: 3731-3736.
6. Sapp E, Kegel KB, Aronin N, Hashikawa T, Uchiyama Y,et al. (2001) Early and progressive accumulation of reactive microglia in the Huntington disease brain. J Neuropathol Exp Neurol 60: 161-172.
7. Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA,et al. (2007) Microglial activation in presymptomatic Huntington's disease gene carriers. Brain 130: 1759-1766.
8. Dalrymple A, Wild EJ, Joubert R, Sathasivam K, Björkqvist M,et al. (2007) Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates. J Proteome Res 6: 2833-2840.
9. Wild E, Magnusson A, Lahiri N, Krus U, Orth M,et al. (2011) Abnormal peripheral chemokine profile in Huntington's disease. PLoS Curr 3: RRN1231.
10. Träger U, Andre R, Lahiri N, Magnusson-Lind A, Weiss A,et al. (2013) HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB-pathway dysregulation. Brain in press.
11. Schindler C, Levy DE, Decker T (2007) JAK-STAT signaling: from interferons to cytokines. J Biol Chem 282: 20059-20063.
12. Shuai K, Liu B (2003) Regulation of JAK-STAT signalling in the immune system. Nat Rev Immunol 3: 900-911.
13. Levy DE, Darnell JE (2002) Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3: 651-662.
14. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G,et al. (2003) Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374: 1-20.
15. Heinrich PC, Behrmann I, Müller-Newen G, Schaper F, Graeve L (1998) Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 334 (Pt 2): 297-314.
16. Huntington Study Group (1996) Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group. Mov Disord 11: 136-142.
17. Shoulson I (1981) Huntington disease: functional capacities in patients treated with neuroleptic and antidepressant drugs. Neurology 31: 1333-1335.
18. Irish JM, Hovland R, Krutzik PO, Perez OD, Bruserud Ø,et al. (2004) Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 118: 217-228.
19. Krutzik PO, Crane JM, Clutter MR, Nolan GP (2008) High-content single-cell drug screening with phosphospecific flow cytometry. Nat Chem Biol 4: 132-142.
20. Perez OD, Nolan GP (2002) Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry. Nat Biotechnol 20: 155-162.
21. Kawashima T, Murata K, Akira S, Tonozuka Y, Minoshima Y,et al. (2001) STAT5 induces macrophage differentiation of M1 leukemia cells through activation of IL-6 production mediated by NF-kappaB p65. J Immunol 167: 3652-3660.
22. Khoshnan A, Ko J, Watkin EE, Paige LA, Reinhart PH,et al. (2004) Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity. J Neurosci 24: 7999-8008.
23. Khoshnan A, Patterson PH (2011) The role of IκB kinase complex in the neurobiology of Huntington's disease. Neurobiol Dis 43: 305-311.